Vascular Endothelial Growth Factor Services
8 services found
by:PIXIUM VISION based inParis, FRANCE
Age-related macular degeneration is the leading cause of severe vision loss and legal blindness in people over the age of 65 in North America and Europe. The global impact is significant with current projected estimates for people living with AMD of around 200 million people worldwide and expected rapid growth due to aging ...
Manufactured by:Salutaris Medical Devices, Inc. (SMD) based inTucson, ARIZONA (USA)
Anti-VEGF Resistant Disease; 20+ million seniors suffer vision loss from wet-AMD (advanced age-related macular degeneration). The current treatment for wet-AMD is frequent (sometimes monthly) injections of anti-VEGF directly into the ...
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
Tamoxifen citrate is an estrogen receptor antagonist and partial agonist which has been shown to induce apoptosis in human malignant glioma cells and to block VEGF production in breast cancer cells. Alfa Chemistry offers high quality tamoxifen citrate to customers which meets the CP & USP standards. Please feel free to contact us for APIs or technical services. Learn more at ...
by:Selvita S.A. based inKrakow, POLAND
Cell and Molecular Biology Department at Selvita performs In vitro comparative studies of biosimilar insulins and insulin analogs as well as battery of various therapeutic antibodies (e.g. TNFα, VEGF and HER2 inhibitors etc.). These studies should be comparative in nature and should be designed to have appropriate sensitivity to detect relevant differences in the response to the similar ...
Manufactured by:XyloCor Therapeutics based inWayne, PENNSYLVANIA (USA)
About the EXACT Trial for Refractory Angina Patients. The EXACT clinical trial is a Phase 1/2 multicenter, open-label, single arm, dose escalation trial. Approximately 12 subjects (N=3 per cohort) who have refractory angina will be enrolled into 4 ascending dose groups, followed by an expansion of the highest tolerated dose with 21 additional subjects. The trial is designed to test the safety and ...
by:Base Pair Biotechnologies, Inc. based inPearland, TEXAS (USA)
Aptamer discovery is a complex process. Customized libraries and selection techniques are employed to achieve selective binding to a target of interest under anticipated conditions. In some cases, selected aptamers may not quite achieve the degree of affinity or stability required for a specific end-use application. In addition, aptamer modification for immobilization or signal generation is ...
Manufactured by:RoosterBio, Inc. based inFrederick, MARYLAND (USA)
Human Mesenchymal Stem/Stromal Cells (hMSCs) are a heterogeneous cell population derived from a variety of tissue and donor sources. As a raw material in emerging cell, gene, and exosome based therapies, understanding the key quality attributes of your hMSC, such as phenotype, function, and growth kinetics are vital to understanding expansion and therapeutic potential. At RoosterBio Inc., we have ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Protein-based macromolecular drugs, typically organic compounds with molecular weights exceeding 1000, depend on cellular biosynthesis and are also known as biologics. Compared to traditional small molecule drugs, protein drugs are characterized by their high potency, strong specificity, low toxicity, clear biological function, and conducive to clinical application. Protein drugs are the ...